ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1211

Allele-Dependent Binding of a Viral Protein to Autoimmune Disease-Associated Genetic Variants

Matthew T. Weirauch1, Daniel Miller1, Leah C. Kottyan2, Ignacio Ibarra3, Sayeed Syed4, Xiaoting Chen1, Erin Zoller1, Arthur Lynch1, Connor Schroeder1, Josh Lee1, Albert Magnussen1, Ally Yang5, Timothy R. Hughes5, Joo-Seop Park1, Charles Vinson4 and John B. Harley6,7, 1Cincinnati Childrens Hospital, Cincinnati, OH, 2Center for Autoimmune Genomics and Etiology, Cincinnati Childrens Hospital, Cincinnati, OH, 3EMBL, Heidelberg, Germany, 4NCI, Bethesda, MD, 5University of Toronto, Toronto, ON, Canada, 6US Department of Veterans Affairs Medical Center, Cincinnati, OH, 7Center for Autoimmune Genomics and Etiology (CAGE), Cincinnati Childrens Hospital, Cincinnati, OH

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Bioinformatics, Gene Expression, genetics, genomics and viruses

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2016

Title: Genetics, Genomics and Proteomics - Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose : Risk factors are known for many diseases, but the etiologies of most autoimmune diseases remain unknown and are idiopathic. Pathogenesis of disease likely involves complex interplay between genetic and environmental risk factors. Specifically, Epstein Barr virus (EBV) has suggestive associations with many autoimmune diseases, and EBV infection is nearly ubiquitous in adults. The molecular mechanisms underlying these associations, however, remain unclear.

Methods: We tested the hypothesis that some autoimmune variants might act by altering the binding of the EBV-encoded transcription factor ZTA, consequently resulting in downstream changes in gene expression. To this end, we comprehensively characterized the DNA binding of ZTA to both methylated and unmethylated DNA sequences using protein binding microarrays (PBMs). Based on these data, we identified plausible causal variants for multiple sclerosis (MS), systemic lupus erythematosus (SLE), and juvenile idiopathic arthritic (JIA) predicted to alter ZTA binding. From among these, we identified variants located within likely regulatory regions in EBV-infected B cells using publically available functional genomic datasets. We screened these candidate variants using electrophoretic mobility shift assays (EMSAs) to identify general differential binding of nuclear factors, and validated differential ZTA binding using EMSA-supershift and DNA Affinity Precipitation Assays coupled with Western blots (DAPA-Westerns).

Results: These experiments revealed three genetic variants, associated with MS, SLE, and JIA, respectively, exhibiting stronger ZTA binding to the risk allele. We provide data showing that each of these variants is associated with genotype-dependent expression in EBV-transformed B cell lines. Using luciferase reporter assays, we further demonstrate that the autoimmune risk alleles result in greater promoter activity.

Conclusion: Collectively, these data demonstrate for the first time that differential binding of a viral protein to a disease-associated genetic variant can result in altered levels of host gene expression in ways that are predicted to influence autoimmune disease risk of MS, SLE, and JIA. Since ZTA is a viral protein, and is expressed throughout human life subsequent to EBV infection, but only in virus infected cells, these results offer a potential therapeutic target for multiple autoimmune diseases.


Disclosure: M. T. Weirauch, None; D. Miller, None; L. C. Kottyan, None; I. Ibarra, None; S. Syed, None; X. Chen, None; E. Zoller, None; A. Lynch, None; C. Schroeder, None; J. Lee, None; A. Magnussen, None; A. Yang, None; T. R. Hughes, None; J. S. Park, None; C. Vinson, None; J. B. Harley, None.

To cite this abstract in AMA style:

Weirauch MT, Miller D, Kottyan LC, Ibarra I, Syed S, Chen X, Zoller E, Lynch A, Schroeder C, Lee J, Magnussen A, Yang A, Hughes TR, Park JS, Vinson C, Harley JB. Allele-Dependent Binding of a Viral Protein to Autoimmune Disease-Associated Genetic Variants [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/allele-dependent-binding-of-a-viral-protein-to-autoimmune-disease-associated-genetic-variants/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/allele-dependent-binding-of-a-viral-protein-to-autoimmune-disease-associated-genetic-variants/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology